Stay updated on Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe footer now shows Revision: v3.5.4, replacing Revision: v3.5.3. This reflects a small platform update rather than any modification to the study details on the page.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedThe page’s displayed software revision has been updated to the next release (from v3.5.2 to v3.5.3), indicating a backend/site version change rather than an update to the clinical trial details.SummaryDifference0.1%

- Check49 days agoChange DetectedFooter shows Revision: v3.5.2, replacing Revision: v3.5.0.SummaryDifference0.1%

- Check78 days agoChange DetectedAdded revision label v3.5.0. Removed revision label v3.4.3.SummaryDifference0.1%

- Check85 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check113 days agoChange DetectedRevision: v3.4.2 was added, and the prior notice about government funding lapse and NIH operating status was removed (associated with Revision: v3.4.1).SummaryDifference0.5%

Stay in the know with updates to Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page.